Insulet | PODD - Assets


Insulet reported $3.17B in Assets for its fiscal quarter ending in June of 2026.





Assets Change Date
Abbott USD 110.43B 23.72B Mar/2026
Align Technology USD 6.42B 103.41M Jun/2026
AtriCure USD 676.64M 32.66M Jun/2026
Baxter International USD 19.79B 55M Jun/2026
Becton, Dickinson and Co. USD 50.83B 4.01B Mar/2026
Boston Scientific USD 45.22B 865M Jun/2026
Cardinal Health USD 56.69B 1.39B Mar/2026
Cooper Companies USD 12.48B 58.1M Mar/2026
Dexcom USD 6.46B 178M Jun/2026
Edwards Lifesciences USD 13.87B 545.9M Jun/2026
Eli Lilly USD 116.58B 4.1B Mar/2026
Globus Medical USD 5.44B 136.79M Mar/2026
ICU Medical USD 4.01B 36.74M Mar/2026
Inogen USD 307.01M 5.03M Sep/2025
Insulet USD 3.17B 177.9M Jun/2026
Integra LifeSciences USD 3.56B 14.24M Jun/2026
J&J USD 201.06B 167M Jun/2026
Medtronic USD 91.48B 139M Dec/2025
Merit Medical Systems USD 2.86B 144.34M Jun/2026
Roche Holding CHF 98.2B 2.5B Jun/2026
Solventum Corp USD 14.1B 197M Mar/2026
Stryker USD 47.93B 1.64B Jun/2026
Tandem Diabetes Care USD 1.15B 272.28M Mar/2026
Teleflex USD 6.78B 164.24M Mar/2026
West Pharmaceutical Services USD 4.08B 33.4M Jun/2026
Zimmer Biomet Holdings USD 22.8B 76.2M Jun/2026